KCM
PFE icon

Kennedy Capital Management’s Pfizer PFE Stock Holding History

Kennedy Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-170,633
Closed -$4.14M – 596
2025
Q2 		$4.14M Sell
170,633
-20,632
-11% -$481K 0.1% 323
2025
Q1 		$4.85M Sell
191,265
-15,621
-8% -$409K 0.12% 293
2024
Q4 		$5.49M Buy
206,886
+40,193
+24% +$1.09M 0.12% 301
2024
Q3 		$4.82M Buy
166,693
+7,514
+5% +$219K 0.11% 326
2024
Q2 		$4.45M Buy
159,179
+15,318
+11% +$422K 0.1% 350
2024
Q1 		$3.99M Buy
+143,861
New +$3.99M 0.08% 375

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Kennedy Capital Management's PFE Position: Q3 2025 in Review

Kennedy Capital Management sold out of Pfizer (PFE) in Q3 2025, closing a stake of 170,633 shares — an estimated $4.14M sold.

Kennedy Capital Management first reported a position in PFE in Q1 2024 and held it in 6 quarters. The position peaked at $5.49M in Q4 2024. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Kennedy Capital Management reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Kennedy Capital Management sold 170,633 Pfizer shares in Q3 2025, an estimated $4.14M.
  • Kennedy Capital Management first reported a position in Pfizer in Q1 2024 and held it in 6 quarters.
  • Kennedy Capital Management's Pfizer position peaked at $5.49M in Q4 2024.
  • 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Kennedy Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.